| Literature DB >> 35408616 |
Marialuisa Formato1, Simona Piccolella1, Christian Zidorn2, Alessandro Vastolo3, Serena Calabrò3, Monica Isabella Cutrignelli3, Severina Pacifico1.
Abstract
In recent years, animal husbandry has aimed at improving the conditions of livestock animals useful for humans to solve environmental and health problems. The formulation of animal feeds or supplements based on antioxidant plant compounds is considered a valuable approach and an alternative for livestock productivity. Forest biomass materials are an underestimated source of polyphenolic compounds whose sustainable recovery could provide direct benefits to animals and, indirectly, human nutrition. In this context, an alcohol extract from leaves of Fagus sylvatica L. was first investigated through an untargeted ultra-high-performance liquid chromatography-high-resolution tandem mass spectrometry (UHPLC-HRMS/MS) approach. Then, it was fractionated into a fatty acid-rich and a polyphenolic fraction, as evidenced by total lipid, phenol, and flavonoid content assays, with antiradical and reducing activity positively correlated to the latter. When tested in vitro with rumen liquor to evaluate changes in the fermentative parameters, a significant detrimental effect was exerted by the lipid-rich fraction, whereas the flavonoid-rich one positively modulated the production of volatile fatty acids (i.e., acetate, butyrate, propionate, etc.).Entities:
Keywords: Fagus sylvatica L.; UHPLC-ESI-QqTOF analysis; flavonoids; in vitro rumen fermentation; polyphenols; volatile fatty acids
Mesh:
Substances:
Year: 2022 PMID: 35408616 PMCID: PMC9000816 DOI: 10.3390/molecules27072217
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Extraction and fractionation of F. sylvatica L. leaf. UAM: ultrasound assisted maceration; LLE: liquid–liquid extraction; Haf: hydroalcoholic fraction; XAD-4 GPC: Gel Permeation Chromatography on Amberlite XAD-4 absorbent resin.
Figure 2(A) (a) Total phenolic content (TPC), expressed as mg of gallic acid equivalents (GAE) per g of extract; (b) total flavonoidic content (TFC), expressed as mg of quercetin equivalents (QUE) per g of extract; (c) total lipidic content (TLC), expressed as mg of oleanolic acid equivalents per g of extract. Values reported are the mean ± SD of three independent measurements. (B) (a) Scavenging capability (SC%) vs. 2,2′-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid (ABTS) radical cation, (b) scavenging capability (SC%) vs. 2,2-diphenyl-1-picrylhydrazy (DPPH) radical, and (c) Fe (III) reducing power (RP) of F. sylvatica extract and organic fractions therefrom. Values reported are the mean ± SD of three independent measurements. (C) PCA analysis based on colorimetric compositive assays and data from antiradical and reducing power tests.
Metabolites tentatively identified in the beech Fs/1/1 alcoholic extract and its Fs/2/1 and Fs/3/2 fractions. RT = retention time; RDB = ring double bond equivalent value. Base peak fragments are reported in bold. detected.
| Peak | Rt | Tentative Assignment | Formula | [M-H]− | [M-H]− | Error | RDB | MS/MS Fragment Ions ( | Fs/1/1 | Fs/2/1 | Fs/3/2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.397 | Quinic acid | C7H12O6 | 191.0557 | 191.0561 | −2.2 | 2 | 191.0557;129.0192; 111.0096; | |||
| 2 | 0.454 | Citric acid | C6H8O7 | 191.0203 | 191.0197 | 3 | 3 | 111.0089; | |||
| 3 | 0.769 | Galloyl hexose | C13H16O10 | 331.0667 | 331.0671 | −1.1 | 6 | 331.0662; 211.0236; | |||
| 4 | 1.311 | Dihydroxybenzoic acid hexoside | C13H16O9 | 315.0720 | 315.719 | 0.1 | 6 | 315.0722, 271.0396, 227.0528, 195.0287, 153.0199; | |||
| 5 | 1.574 | Hydroxybenzoyl hexose | C13H16O8 | 299.0770 | 299.0772 | −0.8 | 6 | 299.0770; 239.0557; 179.0345; 151.0394; | |||
| 6 | 1.890 | Hydroxyphenylacetic acid hexoside | C14H18O8 | 313.0939 | 313.0929 | 3.2 | 6 | 313.0910; | |||
| 7 | 2.038 | 3-O-Caffeoyl quinic acid (cis) | C16H18O9 | 353.0885 | 353.0878 | 2 | 8 | 353.0888; | |||
| 8 | 2.235 | 3-O-Caffeoyl quinic acid (trans) | C16H18O9 | 353.0888 | 353.0878 | 2.2 | 8 | 353.0888; | |||
| 9 | 2.444 | Caffeoyl threonic acid (1) | C13H14O8 | 297.0614 | 297.0622 | 2 | 7 | 179.0340; 161.0245; | |||
| 10 | 2.603 | Caffeoyl acid hexoside | C15H18O9 | 341.0874 | 341.0878 | 7 | −1.2 | 179.0344; | |||
| 11 | 2.822 | Caffeoyl threonic acid (2) | C13H14O8 | 297.0618 | 297.0616 | 0.7 | 7 | 179.0344; | |||
| 12 | 2.839 | 3-O- | C16H18O8 | 337.0926 | 337.0929 | −0.9 | 8 | ||||
| 13 | 3.210 | 3-O- | C16H18O8 | 337.0926 | 337.0929 | −0.9 | 8 | 191.0556; | |||
| 14 | 3.444 | Procyanidin | C30H26O12 | 577.1353 | 577.1352 | 0.3 | 18 | 577.1393, 451.1046, 425.0883, | |||
| 15 | 3.523 | C15H18O8 | 325.0926 | 325.0929 | −0.9 | 7 | 163.0393; | ||||
| 16 | 3.676 | C13H14O7 | 281.0662 | 281.0666 | −1.7 | 7 | 163.0396; 135.0298; | ||||
| 17 | 3.950 | Caffeic acid | C9H8O4 | 179.0357 | 179.0350 | 4.0 | 6 | ||||
| 18 | 4.259 | C13H14O7 | 281.0666 | 281.0666 | 0 | 7 | 177.0570; 163.0399; 145.0293; 135.0298; | ||||
| 19 | 4.624 | 5- | C16H18O9 | 353.0879 | 353.0878 | 0.3 | 8 | ||||
| 20 | 5.665 | Caffeoyl threonic acid (3) | C13H14O8 | 297.0616 | 297.0612 | −1.3 | 7 | 179.0343; 161.0242; | |||
| 21 | 5.693 | Caffeoyl propionic acid | C12H12O6 | 253.0718 | 253.0718 | 0.2 | 6 | 253.0705; 179.0344; | |||
| 22 | 5.759 | 5- | C16H18O9 | 353.0874 | 353.0878 | −1.1 | 8 | ||||
| 23 | 6.090 | Eriodictyol 7- | C21H22O11 | 449.1092 | 449.1089 | −0.3 | 11 | 449.1093; 421.11444; 313.0705; 287.0553; 283.0602; | |||
| 24 | 6.645 | Tuberonic acid | C18H28O9 | 387.1662 | 387.1661 | 0.4 | 5 | ||||
| 25 | 6.981 | 5- | C16H18O8 | 337.0930 | 337.0929 | 0.3 | 8 |
| |||
| 26 | 7.312 | C13H12O7 | 279.0508 | 279.0510 | −0.1 | 8 | 279.0506; 179.0352; | ||||
| 27 | 7.871 | Caffeoylshikimic Acid | C16H16O8 | 335.0766 | 335.0772 | −1.9 | 9 | 335.0766; 179.0355; | |||
| 28 | 8.101 | 5- | C16H18O8 | 337.0925 | 337.0929 | −1.2 | 8 | ||||
| 29 | 8.314 | Caffeoylshikimic Acid | C16H16O8 | 335.0770 | 335.0772 | −0.7 | 9 | ||||
| 30 | 9.288 | C13H12O7 | 279.0508 | 279.0510 | −0.1 | 8 | 179.0348; | ||||
| 31 | 10.091 | Naringenin- | C21H22O10 | 433.1145 | 433.1140 | 1.1 | 11 | 433.1153; 415.1027; 343.0826; 325.0715; | |||
| 32 | 10.712 | Naringenin- | C21H22O10 | 433.1154 | 433.1140 | 1.6 | 11 | 433.1151; 415.1043; 343.0826; 325.0710; | |||
| 33 | 11.960 | Myricetin-3- | C21H20O13 | 479.0839 | 479.0831 | 1.6 | 12 | 479.0841; 317.0286; | |||
| 34 | 14.293 | Quercetin-3- | C21H20O12 | 463.0893 | 463.0882 | 2.4 | 12 | 463.0898; 301.0355; | |||
| 35 | 14.445 | Quercetin-3- | C21H18O13 | 477.0679 | 477.0675 | 0.9 | 13 | 477.0688; | |||
| 36 | 14.728 | Quercetin-3- | C21H20O12 | 463.0891 | 463.0882 | 1.9 | 12 | 463.0899; 301.0355; | |||
| 37 | 14.739 | Kaempferol-3- | C21H18O12 | 461.0733 | 461.0725 | 1.6 | 13 |
| |||
| 38 | 14.940 | Naringenin- | C21H22O10 | 433.1145 | 433.1140 | 1.1 | 11 | 433.1146; 415.1026; 343.0827; 325.0731; | |||
| 39 | 15.083 | Neolignan (I) | C25H34O11 | 509.2033 | 509.2028 | 0.9 | 9 | 509.2033; 491.1937; 461.1823; 367.1396; 313.1288; | |||
| 40 | 15.218 | Neolignan (II) | C25H34O11 | 509.2043 | 509.2028 | 2.9 | 9 | 509.2052; 491.1949; 473.1834: 461.1832; 367.1406; 313.1301; | |||
| 41 | 15.338 | Quercetin-3- | C20H18O11 | 433.0783 | 433.0776 | 1.5 | 12 | 433.0795; 301.0359; | |||
| 42 | 15.423 | Kaempferol-3- | C21H20O11 | 447.0944 | 447.0933 | 2.5 | 12 | 447.0945; 285.0398; | |||
| 43 | 15.517 | Quercetin-3- | C23H22O13 | 505.1003 | 505.0988 | 3.0 | 13 | 505.1018; 463; 0897; 447.0945; 301.0357; | |||
| 44 | 15.743 | Kaempferol-3- | C21H18O12 | 461.0741 | 461.0725 | 3.4 | 13 | 461.0739; | |||
| 45 | 15.903 | Kaempferol-3- | C21H20O11 | 447.0951 | 447.0933 | 4.1 | 12 | 447.0944; 327.0504; 285.0397; | |||
| 46 | 16.237 | Kaempferol-3- | C20H18O10 | 417.0843 | 417.0827 | 3.8 | 12 | 417.0836; 285.0399; | |||
| 47 | 16.456 | Kaempferol-3- | C20H18O10 | 417.0833 | 417.0827 | 1.4 | 12 | 417.0841; 285.0406; | |||
| 48 | 16.748 | Kaempferol-3- | C23H22O12 | 489.1049 | 489.1039 | 2.1 | 13 | 489.1069; 429.0800; 369.0996; | |||
| 49 | 17.073 | Kaempferol-3- | C21H20O10 | 431.0991 | 431.0984 | 1.7 | 12 | 431.1002; 285.0408; | |||
| 50 | 18.232 | Neolignan (III) | C27H38O12 | 553.2313 | 553.2291 | 4.1 | 9 | 553.2330; | |||
| 51 | 19.380 | Kaempferol | C30H26O13 | 593.1325 | 593.1320 | 3.3 | 18 | 593.1322; 447.0935; 307.0813; | |||
| 52 | 19.623 | Kaempferol | C15H10O6 | 285.0404 | 285.0405 | −0.2 | 11 | ||||
| 53 | 18.438 | Dodecenedioic acid | C12H20O4 | 227.1289 | 227.1300 | 4.0 | 3 | ||||
| 54 | 18.867 | 9,12,13-trihydroxy-10,15-octadecadienoic acid | C18H32O5 | 327.2191 | 327.2177 | 0.9 | 3 | 309.2076; 291.1970; 239.1288; 229.1446; 221.1179; | |||
| 55 | 21.080 | Neolignan (IV) | C38H52O16 | 763.3187 | 763.3183 | 0.6 | 13 | 763.3225; | |||
| 56 | 19.695 | 9,12,13-trihydroxy-10-octadecenoic acid | C18H34O5 | 329.2337 | 329.2340 | 2.0 | 2 | 329.2343; 229.1448; | |||
| 57 | 20.297 | Dihydroxyhexadecanoic acid | C16H32O4 | 287.2228 | 287.2240 | 4.2 | 1 | ||||
| 58 | 20.558 | 9,16-diidrossi-octadeca-10, 12,14-trienoic acid (1) | C18H30O4 | 309.2072 | 309.2071 | 0.2 | 4 | 309.2078; 291.1972; 273.1841; 251.1654; 239.1650; 221.1544; 197.1162; 183.1026; | |||
| 59 | 20.846 | 16-idrossi-9-ossooctadeca-12,14-dienoic acid | C18H30O4 | 309.2071 | 309.2071 | −0.1 | 4 | 309.2059; 291.1962; | |||
| 60 | 21.053 | 9,16-diidrossi-octadeca-10, 12,14-trienoic acid (2) | C18H30O4 | 309.2071 | 309.2071 | 0.2 | 4 | 309.2079; | |||
| 61 | 21.350 | 16-idrossi-9-ossooctadeca-6,12,14-trienoic acid | C18H28O4 | 307.1915 | 307.1925 | 3.3 | 5 | 289.1793; 249.1492; 235.1342; 211.1340; 185.1187; 125.0976; | |||
| 62 | 21.350 | Dihydroxyoctadecenoic quinic acid | C25H42O9 | 485.2776 | 485.2756 | 4.1 | 5 | 485.2791; | |||
| 63 | 22.220 | 16-idrossi-9-ossooctadeca-6,12,14,16-tetraenoic acid | C18H26O4 | 305.1758 | 305.1760 | 0.5 | 6 | 305.1744; 249.1498; 205.1587; | |||
| 64 | 22.435 | Kaempferol | C30H26O12 | 577.1368 | 577.1352 | 2.9 | 18 | 577.1389; 431.0988; | |||
| 65 | 22.553 | Kaempferol | C30H26O12 | 577.1357 | 577.1352 | 1.0 | 18 | 577.1382; | |||
| 66 | 22.842 | Kaempferol di- | C38H30O14 | 709.1463 | 709.1590 | 3.8 | 24 | 709.1641; 563.1244; 423.1116; | |||
| 67 | 23.154 | 15,16-dihydroxy-9Z,12Z- | C18H32O4 | 311.2242 | 311.2228 | 1 | 3 | 311.2238; 293.2112; 275.2011; 235.1708; | |||
| 68 | 23.310 | 3- | C48H76O19 | 955.4928 | 955.4908 | 2.1 | 11 | ||||
| 69 | 23.582 | 3- | C48H76O19 | 955.4923 | 955.4908 | 1.6 | 11 | ||||
| 70 | 24.029 | Dihydroxyoctadecenoic acid | C18H34O4 | 313.2382 | 313.2384 | −0.7 | 2 | 313.2377; 295.2270; 277.2163; | |||
| 71 | 24.050 | 3- | C47H74O18 | 925.4801 | 925.4802 | −0.2 | 11 | ||||
| 72 | 24.128 | 3- | C42H66O14 | 793.4395 | 793.4380 | 0.9 | 10 | ||||
| 73 | 24.457 | Kaempferol di- | C39H32O14 | 723.1720 | 723.1719 | 0.1 | 24 | ||||
| 74 | 24.483 | Kaempferol | C40H34O15 | 753.1825 | 753.1823 | −0.3 | 24 | 753.1884; 607.1502; 589.1358; 467.1378; | |||
| 75 | 25.032 | 9-oxooctadeca-10,12-dienoic acid | C18H30O3 | 293.2122 | 293.2130 | 2.7 | 4 | 293.2126; | |||
| 76 | 25.302 | 9-oxooctadeca-10,12,15-trienoic acid | C18H28O3 | 291.1971 | 291.1966 | 1.8 | 5 | ||||
| 77 | 25.611 | 13-hydroxyoctadeca-9,15-dienoic acid | C18H32O3 | 295.2283 | 295.2279 | 1.5 | 3 | 295.2284; 277.2176; | |||
| 78 | 25.783 | 13-hydroxyoctadeca-9,11-dienoic acid | C18H32O3 | 295.2286 | 295.2279 | 1.8 | 3 | ||||
| 79 | 25.937 | 13-oxo-9Z,11E-octadecadienoic acid | C18H30O3 | 293.2121 | 293.2122 | 2.0 | 4 | ||||
| 80 | 26.267 | 9-hydroxyoctadec-12-enoic acid | C18H34O3 | 297.2444 | 297.2435 | 3.0 | 2 | ||||
| 81 | 27.520 | α-Linolenic acid | C18H30O2 | 277.2180 | 277.2173 | 2.5 | 4 |
| |||
| 82 | 28.089 | Linoleic acid | C18H32O3 | 279.2338 | 279.2330 | 3.0 | 3 | ||||
| 83 | 28.552 | Palmitic acid | C16H32O2 | 255.2336 | 255.2330 | 2.5 | 1 | ||||
| 84 | 28.638 | Oleic acid | C18H34O2 | 281.2491 | 281.2486 | 1.8 | 2 |
| |||
| 85 | 29.311 | Stearic acid | C18H36O2 | 283.2656 | 283.2643 | 4.8 | 1 |
Figure 3Total ion current (TIC) chromatograms of Fs/1/1 extract (A), Fs/2/1 fraction (B), and Fs/3/2 fraction (C). The relative content of each extract/fraction in a derivative of benzoic acid (BA) and hydroxycinnamic acid (HCA), as well as of flavonoids (Fl), lignans (Lg), fatty acids (FA), and saponins (Sap), is shown next to each chromatogram.
Figure 4TOF-MS/MS spectra of the acylated kaempferol glycosides (A) 66, (B) 73, and (C) 74 with [M-H]− ions at m/z 709.1463, 723.1720, and 753.1825, which were detected in the lipophilic Fs/2/1 fraction.
(A) Cumulative gas production, organic matter degradability, and fermentation kinetics parameters of different F. sylvatica extracts. OMD: organic matter degradability; OMCV: cumulative volume of gas related to incubated organic matter. (A) Asymptotic gas production, (B) time at which one-half of the asymptote is reached, and (C) switching characteristics of the curve. Rmax: maximum fermentation rate; Tmax: time at which Rmax occurs. * p < 0.01 and ** p < 0.001. (B) In vitro gas production over time of F. sylvatica Fs/1/1 extract and its fractions Fs/2/1 and Fs/3/2 at 50-mg (●) and 200-mg (●) dose levels and control diet (●).
|
|
| |||
|
|
|
| ||
| 50 mg | 200 mg |
| ||
|
| 77.43 | 75.96 | 71.98 | |
|
| 225.59 | 210.02 | 216.75 | |
|
| 194.83 | 175.61 * | 195.34 | |
|
| 25.42 | 28.64 | 34.80 ** | |
|
| 1.93 | 2.04 | 1.80 | |
|
| 14.37 | 16.88 | 17.34 | |
|
| 4.87 | 4.01 | 3.62 | |
|
|
| |||
| 50 mg | 200 mg |
| ||
|
| 77.43 | 74.01 | 45.37 ** | |
|
| 225.59 | 212.13 | 83.37 ** | |
|
| 194.83 | 187.71 | 67.91 ** | |
|
| 25.42 | 29.93 | 17.64 ** | |
|
| 1.93 | 1.61 ** | 1.64 * | |
|
| 14.37 | 13.47 ** | 7.39 ** | |
|
| 4.87 | 4.58 | 2.36 ** | |
|
|
| |||
| 50 mg | 200 mg |
| ||
|
| 77.43 | 76.63 | 74.40 | |
|
| 225.59 | 217.17 | 241.98 | |
|
| 194.83 | 188.47 | 220.53 ** | |
|
| 25.42 | 26.19 | 35.24 ** | |
|
| 1.93 | 2.08 | 2.04 | |
|
| 14.37 | 15.83 | 20.82 | |
|
| 4.87 | 4.77 | 4.12 | |
Figure 5In vitro fermentation rate over time of F. sylvatica Fs/1/1 extract (A) and its fractions Fs/2/1 (B) and Fs/3/2 (C) at the 50-mg (●) and 200-mg (●) dose levels and control diet (●).
Effects of F. sylvatica L. extracts at different doses (50 mg and 200 mg) on fermentation end products after 120 h of incubation. N-NH3: ammonia-N; Total VFAs: total volatile fatty acid (acetate + propionate + butyrate + iso-butyrate + valerate + iso-valerate); BCFA: branched-chain fatty acid proportion (iso-butyrate + iso-valerate)/tVFA; A/P: acetate/propionate ratio. * p < 0.01, ** p < 0.001, and ǂ p < 0.05.
| Control Diet | Fs/1/1 | Fs/2/1 | Fs/3/2 | ||||
|---|---|---|---|---|---|---|---|
| 50 mg | 200 mg | 50 mg | 200 mg | 50 mg | 200 mg | ||
|
| 6.99 ± 0.02 | 6.95 ± 0.01 | 6.96 ± 0.02 | 7.03 ± 0.07 | 7.09 ± 0.04 * | 7.01 ± 0.04 | 6.98 ± 0.03 |
|
| 5.32 ± 0.04 | 5.15 ± 0.05 * | 5.15 ± 0.05 * | 5.08 ± 0.04 ** | 5.06 ± 0.02 ** | 5.26 ± 0.07 | 5.15 ± 0.05 * |
|
| 122.42 ± 2.40 | 92.15 ± 2.64 ** | 80.52 ± 3.85 ** | 92.86 ± 10.7 ** | 49.54 ± 0.46 ** | 137.53 ± 0.03 ǂ | 124.65 ± 2.99 |
|
| 3.32 ± 0.13 | 3.56 ± 0.19 | 2.96 ± 0.18 | 3.70 ± 0.33 | 6.20 ± 0.26 ** | 3.47 ± 0.11 | 2.30 ± 0.17 ** |
|
| 3.08 ± 0.10 | 2.88 ± 0.06 | 2.95 ± 0.29 | 3.42 ± 0.27 | 4.26 ± 0.25 ** | 2.44 ± 0.30 ǂ | 3.15 ± 0.17 |
Effects of F. sylvatica Fs/1/1 extract and its fractions Fs/2/1 and Fs/3/2 at 50-mg and 200-mg dose levels on fermentation end products after 120 h of incubation. AcA = acetic acid; PrA = propionic acid; ButA = Butyric acid; ValA = valeric acid; iso-ButA = iso-butyric acid; iso-ValA = iso-valeric acid. * p < 0.01, ** p < 0.001, and ǂ p < 0.05. In the lower panel, the percentage increase or decrease of each volatile fatty acid was plotted for the different tested dose levels (◼ 50 mg and ◼ 200 mg) vs. FA% in the control diet.
| % VFA | Control Diet | Fs/1/1 | Fs/2/1 | Fs/3/2 | |||
|---|---|---|---|---|---|---|---|
| 50 mg | 200 mg | 50 mg | 200 mg | 50 mg | 200 mg | ||
| AcA | 65.33 ± 0.53 | 65.89 ± 0.06 | 62.90 ± 2.47 ǂ | 67.63 ± 1.35 ǂ | 61.59 ± 1.23 | 68.62 ± 1.38 | 66.24 ± 0.47 |
| PrA | 21.18 ± 0.60 | 23.38 ± 0.69 | 21.39 ± 1.30 | 19.86 ± 1.18 | 14.47 ± 1.24 ** | 28.47 ± 2.99 ** | 21.04 ± 1.00 |
| ButA | 7.37 ± 0.15 | 8.36 ± 0.22 | 5.59 ± 0.45 | 7.84 ± 0.75 | 4.61 ± 2.58 | 10.08 ± 0.04 | 8.38 ± 0.41 |
| ValA | 1.90 ± 0.05 | 1.82 ± 0.22 | 1.45 ± 0.06 ǂ | 1.20 ± 0.05 ** | 1.15 ± 0.05 ** | 1.76 ± 0.14 | 1.83 ± 0.09 |
| iso-ButA | 1.57 ± 0.07 | 1.21 ± 0.04 | 0.89 ± 0.11 * | 1.16 ± 0.02 ǂ | 1.22 ± 0.01 | 1.98 ± 0.42 ǂ | 0.93 ± 0.03 * |
| iso-ValA | 2.57 ± 0.02 | 2.07 ± 0.16 ǂ | 1.50 ± 0.15 ** | 2.09 ± 0.16 ǂ | 2.15 ± 0.32 | 2.62 ± 0.23 * | 2.02 ± 0.10 |
|
|
|
| |||||